会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Method for Differentiating of Human Embryonic Stem Cells Into the Osteoblastic Lineage
    • 将人胚胎干细胞分化成成骨细胞谱系的方法
    • US20100297755A1
    • 2010-11-25
    • US12671362
    • 2007-08-17
    • Yee Sook ChoKyu-Won Lee
    • Yee Sook ChoKyu-Won Lee
    • C12N5/0735
    • A61K31/436C12N5/0654C12N2500/38C12N2500/42C12N2501/04C12N2501/39C12N2501/70C12N2502/02
    • Disclosed are a composition for introducing the osteogenic differentiation of human embryonic stem cells and a method for differentiating human embryonic stem cells into an osteoblastic lineage by inhibiting the mTOR signaling pathway. When cultured in the presence of an inhibitor of the mTOR signaling pathway, human embryonic stem cells are effectively induced to differentiate into an osteoblastic lineage. The osteogenic differentiation of human embryonic stem cells using the method and the composition is useful in examining the development and differentiation mechanism of osteoblasts and the cause of metabolic bone diseases, including osteoporosis. In addition, the method and the composition can be applied to the development of osteogenic differentiation techniques for generating clinically useful, terminally differentiated mature cells or progenitor cells.
    • 公开了用于引入人胚胎干细胞的成骨分化的组合物和通过抑制mTOR信号通路将人胚胎干细胞分化成成骨细胞谱系的方法。 当在mTOR信号通路抑制剂存在下培养时,人胚胎干细胞被有效诱导分化为成骨细胞谱系。 使用该方法和组合物的人胚胎干细胞的成骨分化可用于检查成骨细胞的发育和分化机制以及代谢骨疾病(包括骨质疏松症)的原因。 此外,该方法和组合物可用于开发用于产生临床有用的终末分化的成熟细胞或祖细胞的成骨分化技术。